LEXINGTON, Mass.–(BUSINESS WIRE)–Cadmus Rich, MD, MBA, VP, Medical Affairs and Clinical Development of Inotek, will present at GTCbio’s Ocular Diseases and Drug Discovery Conference on March 21 at 4:55pm PT at The Westin San Diego.
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
Status: Completed,
Condition Summary: Keratoconjunctivitis Sicca
Uncategorized
VIDEO: Landscape of glaucoma treatment in transition
FORT LAUDERDALE, Fla.— At the American Glaucoma Society meeting, OSN Glaucoma Board Member Savak “Sev” Teymoorian, MD, MBA, describes the changing landscape of glaucoma treatment, involving new classes of pharmaceuticals, new ways to deliver treatment and new minimally invasive glaucoma surgery devices.
D.C. Week: Medicare Proposes Change in Part B Drug Payments
(MedPage Today) — Oncologists say new strategy ‘missed the mark’
Uncategorized
VIDEO: AGS attendees offered wide range of learning opportunities
FORT LAUDERDALE, Fla. — At the American Glaucoma Society meeting, OSN Glaucoma Section Editor Thomas W. Samuelson, MD, gives an overview of the meeting’s learning opportunities, ranging widely from basic science to advanced innovative surgery techniques for lowering IOP.
Insurers, Academics Protest High-Cost Drugs, Propose Solutions
(MedPage Today) — Allowing Medicare to negotiate drug prices seen as useful step